The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: The Cxbladder Monitoring Study
Official Title: A Clinical, Non-intervention Study of the Cxbladder Urine Test for the Detection of Recurrent Urothelial Carcinoma (UC)
Study ID: NCT02700659
Brief Summary: The aim of this trial is to determine the performance characteristics of the Cxbladder test for the detection of recurrent urothelial carcinoma (UC) in patients with a recent history of urinary tract UC, who have been treated according to standard practice and are undergoing routine investigative cystoscopy. The gold standard for determination of clinical truth is cystoscopy, plus any follow up investigations relating to the current visit.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Urology Centers of Alabama, Homewood, Alabama, United States
Urology Center of Grove Hill, One Lake Street, New Britain, Connecticut, United States
Florida Urology Associates, Orlando, Florida, United States
Idaho Urologic Institute, Meridian, Idaho, United States
Delaware Valley Urology, LLC, New Jersey, New Jersey, United States
Premier Medical Group of the Hudson Valley, Kingston, New York, United States
Weill Cornell Medical College, Department of Urology, New York, New York, United States
Premier Medical Group of the Hudson Valley, New York, New York, United States
Premier Medical Group of the Hudson Valley, Newburgh, New York, United States
Penn State Hershey Medical Center and College of Medicine, Hershey, Pennsylvania, United States
UT Southwestern Medical Center, Dallas, Texas, United States
Name: Paul J O'Sullivan, PhD
Affiliation: Pacific Edge Limited
Role: STUDY_CHAIR